Cargando…
Decision theory for precision therapy of breast cancer
Correctly estimating the hormone receptor status for estrogen (ER) and progesterone (PGR) is crucial for precision therapy of breast cancer. It is known that conventional diagnostics (immunohistochemistry, IHC) yields a significant rate of wrongly diagnosed receptor status. Here we demonstrate how D...
Autores principales: | Kenn, Michael, Cacsire Castillo-Tong, Dan, Singer, Christian F., Karch, Rudolf, Cibena, Michael, Koelbl, Heinz, Schreiner, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895957/ https://www.ncbi.nlm.nih.gov/pubmed/33608588 http://dx.doi.org/10.1038/s41598-021-82418-7 |
Ejemplares similares
-
Decision Theory versus Conventional Statistics for Personalized Therapy of Breast Cancer
por: Kenn, Michael, et al.
Publicado: (2022) -
Co-expressed genes enhance precision of receptor status identification in breast cancer patients
por: Kenn, Michael, et al.
Publicado: (2018) -
Gene expression information improves reliability of receptor status in breast cancer patients
por: Kenn, Michael, et al.
Publicado: (2017) -
Microarray Normalization Revisited for Reproducible Breast Cancer Biomarkers
por: Kenn, Michael, et al.
Publicado: (2020) -
Molecular dynamics identifies semi-rigid domains in the PD-1 checkpoint receptor bound to its natural ligand PD-L1
por: Kenn, Michael, et al.
Publicado: (2022)